NCT04883827View on ClinicalTrials.gov

Disease Burden and Biology Using Tumor Cell Free DNA in Metastatic Kidney Cancer

CompletedOBSERVATIONAL
Enrollment

180

Participants

Timeline

Start Date

January 6, 2021

Primary Completion Date

December 1, 2023

Study Completion Date

December 1, 2023

Conditions
Renal Cell Carcinoma
Interventions
OTHER

Blood collection

20-40 mL of blood to extract cell free DNA

OTHER

Urine collection

up to 15 mL of urine to extract cell free DNA

Trial Locations (3)

37212

Tennessee Valley Health Care System, Nashville

37232

Vanderbilt University Medical Center, Nashville

77030

The University of Texas MD Anderson Cancer Center, Houston

All Listed Sponsors
collaborator

United States Department of Defense

FED

lead

Vanderbilt-Ingram Cancer Center

OTHER

NCT04883827 - Disease Burden and Biology Using Tumor Cell Free DNA in Metastatic Kidney Cancer | Biotech Hunter | Biotech Hunter